Tumor Immunology

Lab publications

  • Biochimica et Biophysica Acta

    01/03/2020

    Steroids

    Steroid hormone receptors: a south american perspective

    Elizalde PV, Proietti CJ.

  • 29/01/2020

    Oncoimmunology

    Blockade of Stat3 oncogene addiction induces cellular senescence and reveals a cell-nonautonomous activity suitable for cancer immunotherapy

    De Martino M, Tkach M, Bruni S, Rocha D, Mercogliano MF, Cenciarini ME, Chervo MF, Proietti CJ, Dingli F, Loew D, Fernández EA, Elizalde PV, Piaggio E, Schillaci R.

  • Biochimica et Biophysica Acta

    01/12/2019

    Steroids

    Molecular mechanisms underlying progesterone receptor action in breast cancer: insights into cell proliferation and stem cell regulation

    Cenciarini ME, Proietti CJ.

  • 01/06/2019

    Hormones and Cancer

    Nuclear ErbB-2: a Novel Therapeutic Target in ErbB-2-Positive Breast Cancer?

    Cordo Russo RI, Chervo MF, Madera S, Charreau EH, Elizalde PV.

  • Biochimica et Biophysica Acta

    01/05/2018

    Steroids

    Revisiting progesterone receptor (PR) actions in breast cancer: Insights into PR repressive functions

    Proietti CJ, Cenciarini ME, Elizalde PV.

  • Human reproduction open

    01/04/2018

    Human molecular genetics

    Mutations involving the SRY-related gene SOX8 are associated with a spectrum of human reproductive anomalies

    Portnoi MF, Dumargne MC, Rojo S, Witchel SF, Duncan AJ, Eozenou C, Bignon-Topalovic J, Yatsenko SA, Rajkovic A, Reyes-Mugica M, Almstrup K, Fusee L, Srivastava Y, Chantot-Bastaraud S, Hyon C, Louis-Sylvestre C, Validire P, de Malleray Pichard C, Ravel C, Christin-Maitre S, Brauner R, Rossetti R, Persani L, Charreau EH, Dain L, Chiauzzi VA, Mazen I, Rouba H, Schluth-Bolard C, MacGowan S, McLean WHI, Patin E, Rajpert-De Meyts E, Jauch R, Achermann JC, Siffroi JP, McElreavey K, Bashamboo A.

  • 01/02/2018

    Cancer Research

    Tamoxifen resistance in breast cancer is regulated by the EZH2-ERα-GREB1 transcriptional axis

    Wu Y, Zhang Z, Cenciarini ME, Proietti CJ, Amasino MF, Hong T, Yang M, Liao Y, Chiang HC, Kaklamani V, Jeselsohn R, Vadlamudi RK, Huang TH, Li R, De Angelis C, Fu X, Elizalde PV, Schiff R, Brown M, Xu K.

  • Reproductive biology and endocrinology

    28/12/2017

    BMC Cancer

    Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer

    Mercogliano MF, Inurrigarro G, De Martino M, Venturutti L, Rivas MA, Cordo-Russo R, Proietti CJ, Fernández EA, Frahm I, Barchuk S, Allemand DH, Figurelli S, Deza EG, Ares S, Gercovich FG, Cortese E, Amasino M, Guzmán P, Roa JC, Elizalde PV, Schillaci R.

  • Cells

    16/08/2017

    Genes (Basel)

    Distribution of FMR1 and FMR2 Repeats in Argentinean Patients with Primary Ovarian Insufficiency

    Espeche LD, Chiauzzi V, Ferder I, Arrar M, Solari AP, Bruque CD, Delea M, Belli S, Fernández CS, Buzzalino ND, Charreau EH, Dain LB.

  • Immunology and Cell Biology

    03/04/2017

    Immunology and Cell Biology

    Inhibition of MHC-I by Brucella abortus is an early event during infection and involves EGFR pathway

    Velásquez LN, Milillo MA, Delpino MV, Trotta A, Mercogliano MF, Pozner RG, Schillaci R, Elizalde PV, Giambartolomei GH, Barrionuevo P.